Literature DB >> 32048072

Spectrum and prognosis of renal histopathological lesions in 56 Chinese patients with rheumatoid arthritis with renal involvement.

Ti Zhang1, Shaoshan Liang1, Xiaopian Feng1, Manna Li1, Houan Zhou1, Caihong Zeng1, Jiong Zhang1, Zhen Cheng2.   

Abstract

The objective of the study was to evaluate the characteristics and prognosis of 56 patients with rheumatoid arthritis (RA)-associated renal involvement by retrospective review of their renal biopsy specimens. Included in this cross-sectional study were 56 RA patients with renal involvement, in whom renal biopsy was performed to analyze the histological pattern and renal prognosis. IgA nephropathy (IgAN) was detected in 48.2% of the 56 included patients as the most common renal histological pattern, followed by membranous nephropathy (MN) in 23.2% cases, focal segmental glomerular sclerosis (FSGS) in 19.6% cases, chronic interstitial nephritis (CIN) in 5.4% cases, membranoproliferative glomerulonephritis (MPGN) in 1.8% cases, and non-IgA mesangial proliferative glomerulonephritis in 1.8% cases. No significant relationship was observed between the histopathologic type and the RA duration, joint deformity or treatment. Renal dysfunction was mainly found in IgAN patients, and MN occurred more frequently in older patients. Renal function decline occurred in two IgAN patients, one with FSGS and the other with MPGN. Another CIN patient progressed to dialysis during the follow-up period. The patients with renal function decline had a significantly higher level of serum creatinine at presentation. The high percentage of glomeruli sclerosis and interstitial fibrosis/tubular atrophy was also related to renal function decline. IgAN was the major RA-associated renal histological lesion in our series. Renal biopsy can provide useful information about the histological pattern and renal prognosis and therefore should be considered in RA patients with renal involvement.

Entities:  

Keywords:  Histopathology; Mesangial proliferative glomerulonephritis; Rheumatoid arthritis

Mesh:

Year:  2020        PMID: 32048072     DOI: 10.1007/s10238-019-00602-6

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  24 in total

Review 1.  Microvascular endothelial dysfunction in rheumatoid arthritis.

Authors:  Romain Bordy; Perle Totoson; Clément Prati; Christine Marie; Daniel Wendling; Céline Demougeot
Journal:  Nat Rev Rheumatol       Date:  2018-07       Impact factor: 20.543

2.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Authors:  Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Journal:  Lancet       Date:  2010-05-17       Impact factor: 79.321

3.  The kidney in rheumatoid arthritis. A study based on renal biopsies.

Authors:  M I Salomon; G Gallo; T P Poon; M V Goldblat; V Tchertkoff
Journal:  Nephron       Date:  1974       Impact factor: 2.847

Review 4.  Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy.

Authors:  Nicola Maruotti; Francesca d'Onofrio; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2014-11-27       Impact factor: 3.984

5.  Cyclosporin a induces renal episodic hypoxia.

Authors:  M Fähling; S Mathia; J Scheidl; R Abramovitch; Z Milman; A Paliege; H Peters; P B Persson; S N Heyman; C Rosenberger
Journal:  Acta Physiol (Oxf)       Date:  2016-10-18       Impact factor: 6.311

6.  Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis.

Authors:  H J Helin; M M Korpela; J T Mustonen; A I Pasternack
Journal:  Arthritis Rheum       Date:  1995-02

7.  Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis.

Authors:  M Nakano; M Ueno; S Nishi; H Shimada; H Hasegawa; T Watanabe; T Kuroda; T Sato; Y Maruyama; M Arakawa
Journal:  Clin Nephrol       Date:  1998-09       Impact factor: 0.975

8.  Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis.

Authors:  Chen Yu; Mengtao Li; Xinwang Duan; Yongfei Fang; Qin Li; Rui Wu; Shengyun Liu; Yongfu Wang; Zhenbiao Wu; Xiaofei Shi; Zhenyu Jiang; Yanhong Wang; Evelyn D Hsieh; Shangyi Jin; Nan Jiang; Qian Wang; Yan Zhao; Xinping Tian; Xiaofeng Zeng
Journal:  Clin Exp Rheumatol       Date:  2018-03-21       Impact factor: 4.473

9.  Membranous nephropathy in rheumatoid arthritis: a case report.

Authors:  N Maruotti; A Corrado; A Gaudio; F P Cantatore
Journal:  Clin Exp Rheumatol       Date:  2009 Sep-Oct       Impact factor: 4.473

10.  Focal segmental glomerulosclerosis lagged behind the onset of rheumatoid arthritis by 7 years: A case report and literature review.

Authors:  Yang Liu; Hong-Yan Wen; Li-Hua Wang; Chen Wang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

View more
  4 in total

Review 1.  Autoimmune-mediated renal disease and hypertension.

Authors:  Erika I Boesen; Rahul M Kakalij
Journal:  Clin Sci (Lond)       Date:  2021-09-17       Impact factor: 6.876

2.  Frequency of Renal Function Parameter Abnormalities in Patients with Psoriatic Arthritis and Rheumatoid Arthritis: Real-World Evidence from Clinical Practice.

Authors:  Fabiola Atzeni; Pietro Muto; Javier Rodríguez-Carrio; Ignazio Francesco Masala
Journal:  J Clin Med       Date:  2022-02-16       Impact factor: 4.241

3.  Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis.

Authors:  Suo Zhang; Yu-Lan Chen; Cui-Lian Liu; Jing-Yi Xie; Bao-Dong Sun; Dong-Zhou Liu
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

4.  Use of biologic agents and methotrexate improves renal manifestation and outcome in patients with rheumatoid arthritis: a retrospective analysis.

Authors:  Masato Sawamura; Naoki Sawa; Masayuki Yamanouchi; Daisuke Ikuma; Akinari Sekine; Hiroki Mizuno; Masahiro Kawada; Rikako Hiramatsu; Noriko Hayami; Eiko Hasegawa; Tatsuya Suwabe; Junichi Hoshino; Kei Kono; Keiichi Kinowaki; Kenichi Ohashi; Yutaka Yamaguchi; Yoshifumi Ubara
Journal:  Clin Exp Nephrol       Date:  2021-11-30       Impact factor: 2.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.